Introducing a unique competition and training programme that showcases biotech, medtech and digital health start-ups to leading experts and investors across Europe. The programme recognises and awards the very best business concepts, fast-tracking start-ups to become part of the EIT Health Community of world-leading companies.
This one-of-a-kind, rigorous and rewarding competition spotlights start-ups that offer best value to users and customers. Throughout the process, start-ups receive intensive training as they build their credibility and visibility through pan-European exposure. Finalists are showcased at the EIT Health Summit as they go head-to-head for their share of the €210,000 investment prize fund with the Audience Award Winner displayed on the New York Nasdaq Tower.
Deadline to apply: 16 March 2021
Pitch your business plan at the EIT Health Summit for a chance to win a cash prize of up to €40,000
Optimise your business plan and strengthen your ability to confidently and successfully pitch your start-up with top experts
Increase awareness of your health service or product among renowned healthcare experts and investors
Connect with other ambitious healthcare start-ups and world-leading biotech, medtech and digital health companies in the EIT Health network
Tap into the EIT Health ecosystem of acceleration services for support in key areas, such as validation and international expansion
The Audience Award Winner will have their start-up showcased on the New York Nasdaq Tower
Receive mentoring and coaching vouchers, travel and accommodation grants and special ‘in kind’ awards from our sponsors
By taking part in the EIT Health Catapult, successful start-ups receive high-quality, bespoke training in business modelling and planning, investment deal negotiation and specialised pitch preparation, while gaining access to Europe’s top healthcare experts and investors.
Together, these factors are creating a European-wide success story:
The Catapult is open to all start-ups and spin-offs that are:
Apply
Join our Catapult webinar to learn more about the programme and find out if it is right for you. All you need to do is register below to secure your place:
10 March 2021 at 10:00 AM CET
“EIT Health Catapult is a shortcut to enable access to professionally prepared investment cases. Companies are sourced systematically from across Europe and offer investors a chance to meet companies that have been de-risked.”
Kerry Ritz, Board Member and Angel Investor
“The pitch training was remarkable. We had never been as prepared to pitch as we were during this competition, undoubtedly.”
Allan Rodriguez, VitaDx CEO, 2nd place in Medtech category 2018
“The Catapult prize allowed us to convince a pool of Business Angels to invest more than €1M in the creation of DENDROGENIX, a new spin-off Biotech company of Affichem in Belgium, with a worldwide ambition.”
Stéphane Silvente, Affichem & Dendrogenix CEO, Biotech Finalist in 2017
“Catapult is an amazing opportunity for biotech, medtech and digital health companies to meet colleagues, learn from them and share best practices. You also have access to motivated mentors to fine tune your final pitch and business model.”
Montserrat Barcelo Riera, Mentor, Vice President Europe at Veristat Inc.
Submit an application through our portal by 16 March 2021. Have your company, team and product/service information to hand, as you will need it to apply.
Apply
Here’s your opportunity to help finance an innovation in biotech, medtech and digital health with the potential to shape the future of healthcare and benefit millions of people. Contact us to learn more about these promising start-ups.
Our rigorous application process identifies the very best start-ups ready to take their business to the next level
All Catapult start-ups have a valuation of at least €1M and already have €500K in funding or revenue – they’re ready for take-off
Build contacts with tomorrow’s European healthcare leaders through a programme of year-round events
Access our community of leading experts and investors across Europe, and network with other leading investors and mentors
